 |
| Genvoya |
T.A.T - The U.S. Food and Drug Administration announced
today its approval of a new all-in-one pill to treat HIV patients
that includes a new version of the drug tenofovir, which researchers think will
help reduce side effects from the multi-drug regimens used for HIV.
The
pill, called Genvoya, includes doses of elvitegravir, cobicistat, emtricitabine
and tenofovir alafenamide and is meant especially for patients over age 12 who
weigh at least 77 pounds and have not previously been treated for HIV.
